Results 11 to 20 of about 107,286 (246)

Heart failure with preserved ejection fraction – onset [PDF]

open access: yesБългарска кардиология, 2021
During these more than 20 years of evolution in understandings of the mechanisms of heart failure (HF) with preserved fractional ejection, there has been a rich variety of terminology, including „diastolic heart failure“, „heart failure with preserved ...
Branimir Kanazirev
doaj   +3 more sources

Targeting Adipose Tissue Function Protects Against Heart Failure with Preserved Ejection Fraction

open access: goldAdvanced Science, EarlyView.
This study explores the role adipose tissue (AT) phenotypes have in determining cardiovascular outcomes in an obesity‐related heart failure with preserved ejection fraction (HFpEF) model. Pharmacological induction of thermogenesis promoted resilience to HFpEF‐induced remodeling of AT and conferred cardioprotection. Surgical and genetic models confirmed
Jordan Jousma   +11 more
openalex   +2 more sources

Blood Immune Cell Alterations in Patients with Hypertensive Left Ventricular Hypertrophy and Heart Failure with Preserved Ejection Fraction

open access: yesJournal of Cardiovascular Development and Disease, 2023
(1) Background: Chronic inflammation and fibrosis are key players in cardiac remodeling associated with left ventricular hypertrophy (LVH) and heart failure with a preserved ejection fraction (HFpEF). Monocytes and T-helpers (Th) are involved in both pro-
Artem Ovchinnikov   +6 more
doaj   +1 more source

Diagnostic Value of Serum Concentration of Galectin-3 in Patients With Heart Failure With Preserved Ejection Fraction

open access: yesFrontiers in Cardiovascular Medicine, 2022
BackgroundAlthough the predictive value of galectin-3 for heart failure with preserved ejection fraction has been demonstrated, the diagnostic value remains unclear.
Jing Jiang   +5 more
doaj   +1 more source

Therapeutic Stalemate in Heart Failure With Preserved Ejection Fraction

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
The findings of randomized trials of neurohormonal modulation have been neutral in heart failure with preserved ejection fraction and consistently positive in heart failure with reduced ejection.
Rohan Samson, Thierry H. Le Jemtel
doaj   +1 more source

Diabetes Mellitus and Heart Failure With Preserved Ejection Fraction: Role of Obesity

open access: yesFrontiers in Physiology, 2022
Heart failure with preserved ejection fraction is a growing epidemic and accounts for half of all patients with heart failure. Increasing prevalence, morbidity, and clinical inertia have spurred a rethinking of the pathophysiology of heart failure with ...
Aneesh Dhore-patil   +7 more
doaj   +1 more source

Comparing the Diagnostic Performance of HFA-PEFF and H2FPEF Scoring Systems in Heart Failure with Preserved Ejection Fraction Patients: Insights from the APOLLON Registry

open access: yesAnatolian Journal of Cardiology, 2023
Background: Heart failure with preserved ejection fraction is a complex and heterogeneous clinical syndrome, poses significant diagnostic challenges.
Gurbet Özge Mert   +19 more
doaj   +1 more source

Heart Failure With Preserved Ejection Fraction

open access: yesJournal of Osteopathic Medicine, 2015
Abstract Heart failure with preserved ejection fraction (HFpEF) is a complex clinical condition. Initially called diastolic heart failure, it soon became clear that this condition is more than the opposite side of systolic heart failure. It is increasingly prevalent and lethal.
Felix J, Rogers   +3 more
  +5 more sources

Sacubitril/valsartan in patients with mildly reduced or preserved ejection fraction and worsening heart failure: A review

open access: yesТерапевтический архив, 2023
Heart failure with mildly reduced ejection fraction and heart failure with preserved ejection fraction are associated with significant morbidity and mortality, as well as growing economic burden.
Igor V. Zhirov   +2 more
doaj   +1 more source

Heart failure with preserved ejection fraction. [PDF]

open access: yesJournal of geriatric cardiology : JGC, 2013
Progressive aging of the population and prolongation of life expectancy have led to the rising prevalence of heart failure (HF). Despite the improvements in medical therapy, the mortality rate of this condition has remained unacceptably high, becoming the primary cause of death in the elderly population.
Whalley, Gillian, Rigolli, Marzia
openaire   +5 more sources

Home - About - Disclaimer - Privacy